期刊文献+

急性冠脉综合征患者炎性标记物与斑块稳定性的研究

下载PDF
导出
摘要 目的观察急性冠脉综合征(ACS)患者炎性标记物与斑块稳定性的关系。方法对40例ACS患者和35例稳定型心绞痛(SA)患者测定血清高敏C反应蛋白(hs-CRP)、基质金属蛋白酶-9(MMP-9)、组织型基质金属蛋白酶抑制剂-1(TIMP-1)的含量,分析与冠状动脉造影狭窄程度积分之间的关系。结果ACS组血清hs-CRP、MMP-9含量均高于SA组(P<0.05),血清TIMP-1含量在ACS组和SA组之间差异无统计学意义(P=0.254),ACS组MMP-9含量与hs-CRP呈正相关(r=0.571,P<0.05),冠状动脉狭窄程度积分与hs-CRP、MMP-9含量无相关性(r=0.091,P>0.05;r=0.110。P>0.05)。结论hs-CRP、MMP-9的浓度与冠状动脉的狭窄的程度无明显关系,与斑块的稳定性有关,炎症导致了斑块的不稳定性,参与了ACS的发生。
出处 《中西医结合心脑血管病杂志》 2008年第8期967-968,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献8

  • 1Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease[J]. Am Coll Cardiol,1983, 51;606.
  • 2程文立,柯元南.炎性血清标记物与动脉硬化斑块稳定性的研究近况[J].心血管病学进展,2005,26(3):262-265. 被引量:19
  • 3Hong MK, Mintz GS, Lee CW, et al. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: A three-vessel intravascular ultrasound study in 235 patients[J]. Circulation. 2004, 110:928-933.
  • 4Loftus IM, Naylor AR, Goodall S, Increased matrix metalloproteinases- 9 activity in unstable carotid plaque. A potential role on acute plaque disruption[J]. Stroke. 2003, 31(1):40-47.
  • 5Kai H, Ikeda H, Yasukawa H. etal. Peripheral levels of matrix metalloproteinases - 2 and matrix metalloproteinases - 9 are elevated in patients with acute coronary syndromes[J]. J Am Coll Cardiol, 1998, 32(2):368-372.
  • 6Higo S, Uematsu M, Yamagishi M, et al. Elevation of plasma ma trix metalloproteinases - 9 in the culprit coronary artery in patients with acute myocardial infarction: Clinical evidence from distal pro tection[J].Cir J, 2005, 69(10):1180- 1185.
  • 7Inokubo Y, Hanada H, Ishizaka H,etal, Plasma levels of matrix metalloproteinases - 9 and tissue inhibitor of metalloproteinases - 1 are increasing in coronary circulation in acute coronary syndromes [J].Am Heart J, 2001, 141:211 -217.
  • 8Falk E, ShahPK,Fuster V. Coronary plaque disruption[J]. Circulation,1995,92:657.

二级参考文献37

  • 1Jaakkola k,Jalkanen S,Kaunis MK,et al.Vascular adhesion protein-1,intercellular adhesion molecule-l and P-selectin mediate leukocyte binding to ischemic heart in humans[J].J Am Coll Cardiol,2003,36(1):122-129.
  • 2Mulvihill NT,Foley JB,Murphy R,et al.Evidence of prolonged inflammation in unstable angina and non-Q wave myocardial infarction[J].J Am Coll Cardiol,2000,36:1210-1216.
  • 3Lug G, Arveiler D,Evans A,et al.Circulating soluble adhesion moleculesICAM-1 and VCAM-1 and incident coronary heart disease:the PRIME study[J].Atherosclerosis,2003,170(1):169-176.
  • 4Guray U,Erbay AR,Gury Y,et al.Levels of souble adhesion molecules in various clinical presentations of coronary atherosclerosis[J].Int J Cardiol,2004,96(2):235-240.
  • 5Doo YC,Han SJ,Lee J,et al.Associations among oxidized low-density lipoprotein antibody,C-reactive protein,interleukin-6,and circulating cell adhesion molecules in patients with unstable angina pectoris[J].Am J Cardiol,2004,93(5):554-558.
  • 6Orbe J,Fernandez l,Rodriguez JA.Different expression of MMPs/TIMP-1 in human atherosclerotic lesion.Relation to plaque features and vascular bed[J].Atherosclerosis,2003,170(2):269-276
  • 7Beaudeux JL,Giral P,Bruckert E,et al.Matrix metalloproteinases,inflammation and atherosclerosis:therapeutic perspectives[J].Clin Chem Lab Med,2004,42(2):121-131.
  • 8Henney AM,wakeley PR,Davies MJ,et al.Localization if stromelysin gene expression in atherosclerotic plaqued by in situ hybridization[J].Proc Natl Acas Sci USA,1991,88(18):8154-8158.
  • 9Inokubo Y,Hanada H,Ishizaka H,et al.Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome[J].Am Heart J,2001,141(2):211-217.
  • 10Kai H,Ikeda H,Yasukawa H,et al.Peripheral blood levels of matrix metalloproteases-2 and are elevated in patients with acute coronary syndroms[J].J Am Coll Cardiol,1998,32(2):368-372.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部